American Heart News - Heart News

SEPTEMBER 7, 2024

Research Highlights: Favorable cardiovascular health in early pregnancy, as measured by the American Heart Association's Life's Essential 8 (LE8) cardiovascular health score, was linked to lower risk of preeclampsia and gestational hypertension,

Hypertension 116

Hypertension Research 116

HCPLive

SEPTEMBER 7, 2024

Semaglutide lowers rates of cardiovascular and COVID-19-related deaths in patients with overweight/obesity, offering promising cardio-metabolic and non-cardiovascular benefits.

COVID-19 115

COVID-19 Obesity 115

Dr. Smith's ECG Blog

SEPTEMBER 7, 2024

A 70-something y.o. male presents to triage with shortness of breath. He reports significant chest pain at the base of his scapula on the right side along with new shortness of breath. ECG 1 at time zero EARLY REPOLARIZATION ABNORMAL ECG ED final official overread: "early repol vs hyperacute T, minimal changes from previous (previous shown below)" What do YOU think?

Chest Pain 115

Chest Pain Myocardial Infarction STEMI Critical Care 115

Med Page Today

SEPTEMBER 7, 2024

(MedPage Today) -- TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange, MD, president of the Texas Tech University Health Sciences Center.

94

94

HCPLive

SEPTEMBER 7, 2024

People with chronic liver disease were more likely to experience healthcare barriers and require recurrent acute care compared to those with COPD and/or CVD.

Chronic Disease 72

Chronic Disease 72

The American Journal of Cardiology

SEPTEMBER 7, 2024

Publication date: Available online 6 September 2024 Source: The American Journal of Cardiology Author(s): C. Charles Jain, Alexander C. Egbe, Thomas G. Allison, Alexander van de Bruaene, Barry A. Borlaug, Heidi M. Connolly, Luke J. Burchill, William R.

Exercise 40

Exercise 40

HCPLive

SEPTEMBER 7, 2024

These real-world findings highlight the benefits of sustained dupilumab therapy for individuals with chronic rhinosinusitis with nasal polyps.

52

52

HeartRhythm

SEPTEMBER 7, 2024

Cardiac device therapy is frequently required for individuals with adult congenital heart disease (ACHD), whether it be for bradyarrhythmia, ventricular tachyarrhythmia, or cardiac resynchronization therapy (CRT). Compared to a standard adult population, there are special considerations when planning device implantation in ACHD patients, especially those with complex anatomy.

Congenital Heart Disease 40

Congenital Heart Disease Congenital Heart Disease Article 40